Aurora's Greybeard Brand Wins KIND Magazine's 'Best Diamonds of the Year' Award

<br /> Aurora’s Greybeard Brand Wins KIND Magazine’s ‘Best Diamonds of the Year’ Award<br />

Canada NewsWire

NASDAQ | TSX: ACB

EDMONTON, AB

,

Dec. 9, 2022

/CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is excited to announce its Greybeard Cannabis Co. brand has won KIND Magazine’s ‘Best Diamonds of the Year’ award, as voted by hundreds of budtenders, store managers and independent cannabis retail owners across

Canada

.

Greybeard is known for its premium cannabis flower, vapes and concentrates including Trufflez Diamonds & Sauce and FPOG Live Resin Diamonds & Sauce. The Greybeard brand joined Aurora’s portfolio when the company acquired Thrive Cannabis earlier this year.

“We’re proud to be recognized by some of the most important and influential members of the cannabis industry – retailers and budtenders,” says

Geoff Hoover

, Senior Vice President of Consumer at Aurora Cannabis. “This award is a testament to our continued commitment to quality and our team’s unwavering focus and passion for delivering only the best products for our consumers.”

Greybeard was also nominated for ‘Best in Vape Cartridge of the Year’, ‘Rosin of the Year’, and ‘Resin of the Year’. Aurora’s San Rafael ’71 brand was also nominated in the ‘Resin of the Year’ category.

For more information about Aurora and its portfolio of brands, visit

auroramj.com

.

About Aurora:

Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in

Edmonton, Alberta

, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes

Aurora Drift

,

San Rafael ’71

,

Daily Special

,

Whistler

,

Being

and

Greybeard

, as well as CBD brands,

Reliva

and

KG7

.

Medical cannabis

brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. Aurora also has a controlling interest in

Bevo Farms

,

North America’s

leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at

www.auroramj.com

and follow us on

Twitter

and

LinkedIn

.

Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB”.

Forward-looking Information

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management’s estimates of consumer demand in

Canada

and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management’s estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated

September 30, 2022

(the “AIF”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at

www.sedar.com

and filed with and available on the SEC’s website at

www.sec.gov

. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.